Immunohistochemical analysis revealed widespread TROP-2 expression (98.8% of samples), with high levels linked to low-grade UTUC (p = 0.043) and intense staining (mean H-score 227 ± 63) across both cohorts. The gene discussed is TACSTD2; the disease is renal pelvis/ureter urothelial carcinoma.